These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16608503)

  • 21. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
    Legnani C; Cini M; Cosmi B; Poggi M; Boggian O; Palareti G
    Haematologica; 2004 Nov; 89(11):1347-51. PubMed ID: 15531457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
    Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
    Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
    Reich LM; Heiss G; Boland LL; Hirsch AT; Wu K; Folsom AR
    Vasc Med; 2007 Nov; 12(4):267-73. PubMed ID: 18048462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S; Hillarp A; Ekholm C; Mattson E; Halldén C; Friberg B
    Thromb Haemost; 2008 Jun; 99(6):1013-8. PubMed ID: 18521502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patients.
    Santamaría A; Oliver A; Borrell M; Belvís R; Martí-Fábregas J; Mateo J; Fontcuberta J
    Int J Clin Pract; 2007 Nov; 61(11):1819-23. PubMed ID: 17511793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hemostatic profiles of patients with Type O and non-O blood after acute normovolemic hemodilution with 6% hydroxyethyl starch (130/0.4).
    Kang JG; Ahn HJ; Kim GS; Hahm TS; Lee JJ; Gwak MS; Choi SJ
    Anesth Analg; 2006 Dec; 103(6):1543-8. PubMed ID: 17122237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.
    Martinelli N; Girelli D; Ferraresi P; Olivieri O; Lunghi B; Manzato F; Corrocher R; Bernardi F
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):125-9. PubMed ID: 17287628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.
    Chougule A; Rajpal S; Ahluwalia J; Bose SK; Masih J; Das R; Kumar N; Malhotra P; Suri V
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):58-63. PubMed ID: 26340461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand factor (vWF) antigen levels and function in healthy Thais.
    Rojnuckarin P; Akkawat B; Intragumtornchai T
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1292-7. PubMed ID: 16438160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of ischemic colitis associated with myocardial infarction: an analysis of 23 patients.
    Cappell MS; Mahajan D; Kurupath V
    Am J Med; 2006 Jun; 119(6):527.e1-9. PubMed ID: 16750970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
    Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
    Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological determinants of bleeding in patients with heterozygous factor XI deficiency.
    Guéguen P; Galinat H; Blouch MT; Bridey F; Duchemin J; Le Gal G; Abgrall JF; Pan-Petesch B
    Br J Haematol; 2012 Jan; 156(2):245-51. PubMed ID: 22098495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of family history of myocardial infarction in young women.
    Patel MJ; de Lemos JA; Philips B; Murphy SA; Vaeth PC; McGuire DK; Khera A
    Am Heart J; 2007 Sep; 154(3):454-60. PubMed ID: 17719289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Br J Haematol; 2009 Apr; 145(1):121-7. PubMed ID: 19170679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N; Coppens M; Veeger NJ; Bom VJ; Middeldorp S; Hamulyak K; Prins MH; Büller HR; van der Meer J
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort.
    Morange PE; Tregouet DA; Frere C; Saut N; Pellegrina L; Alessi MC; Visvikis S; Tiret L; Juhan-Vague I
    Br J Haematol; 2005 Jan; 128(1):91-9. PubMed ID: 15606554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between short activated partial thromboplastin times, thrombin generation, procoagulant factors and procoagulant phospholipid activity.
    Mina A; Favaloro EJ; Koutts J
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):203-7. PubMed ID: 22322136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.